Chronic disease management is a new model in the treatment of multiple myeloma

Multiple myeloma, the second most common hematologic malignancy, is characterized by the clonal expansion of plasma cells. Due to advances of new drugs and new therapies, the treatment of multiple myeloma patients has changed, and survival has become longer and longer. Therefore, chronic disease management model will become a new model for the treatment of multiple myeloma. In this review, we will discuss the concept of chronic disease management, the necessity, application, value, and benefit of chronic disease management in multiple myeloma.